Azilsartan Reduced TNF-α and IL-1β Levels, Increased IL-10 Levels and Upregulated VEGF, FGF, KGF, and TGF-α in an Oral Mucositis Model

Angiotensin receptor 1 blockade reduces secretion of inflammation associated cytokines from cultured human carotid atheroma and vascular cells in association with reduced extracellular signal regulated kinase expression and activation

(2014) Paula Clancy et al.   ATHEROSCLEROSIS

Effects of Irbesartan on Inflammatory Cytokine Concentrations in Patients with Chronic Glomerulonephritis

(2014) Shuichi Tsuruoka et al.   INTERNAL MEDICINE

Azilsartan Increases Levels of IL-10, Down-Regulates MMP-2, MMP-9, RANKL/RANK, Cathepsin K and Up-Regulates OPG in an Experimental Periodontitis Model

(2014) Aurigena Antunes de Araújo et al.   PLoS One

Irbesartan, an angiotensin receptor blocker, exhibits metabolic, anti-inflammatory and antioxidative effects in patients with high-risk hypertension

(2013) Isao Taguchi et al.   HYPERTENSION RESEARCH

Effect of telmisartan on levels of IL-1, TNF-α, down-regulated COX-2, MMP-2, MMP-9 and RANKL/RANK in an experimental periodontitis model

(2013) Aurigena A. Araújo et al.   JOURNAL OF CLINICAL PERIODONTOLOGY

Olmesartan decreases IL-1β and TNF-α levels; downregulates MMP-2, MMP-9, COX-2, and RANKL; and upregulates OPG in experimental periodontitis

(2013) Aurigena Antunes Araújo et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

Low-Level Laser in Prevention and Treatment of Oral Mucositis in Pediatric Patients with Acute Lymphoblastic Leukemia

(2013) Jurema Freire Lisboa de Castro et al.   PHOTOMEDICINE AND LASER SURGERY

Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients

(2013) Ourania Nicolatou-Galitis et al.   SUPPORTIVE CARE IN CANCER

Anti-inflammatory and anti-oxidant activities of olmesartan medoxomil ameliorate experimental colitis in rats

(2013) Marwa M. Nagib et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Angiotensin II AT1receptor blockers as treatments for inflammatory brain disorders

(2012) Juan M. Saavedra   CLINICAL SCIENCE

Healing acceleration in hamsters of oral mucositis induced by 5-fluorouracil with topical Calendula officinalis

(2012) Nader Tanideh et al.   Oral Surgery Oral Medicine Oral Pathology Oral Radiology

Wound Macrophages as Key Regulators of Repair

(2011) Samielle K. Brancato et al.   AMERICAN JOURNAL OF PATHOLOGY

Effects of the Angiotensin Receptor Blocker Azilsartan Medoxomil Versus Olmesartan and Valsartan on Ambulatory and Clinic Blood Pressure in Patients With Stages 1 and 2 Hypertension

(2011) William B. White et al.   HYPERTENSION

Cancer treatment-induced oral mucositis: a critical review

(2011) A. Rodríguez-Caballero et al.   INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY

Molecular and cellular effects of azilsartan

(2011) Takashi Kajiya et al.   JOURNAL OF HYPERTENSION

Effect of atorvastatin on 5-fluorouracil-induced experimental oral mucositis

(2010) C. A. C. X. Medeiros et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Biology of interleukin-10

(2010) Robert Sabat et al.   CYTOKINE & GROWTH FACTOR REVIEWS

In Vitro Antagonistic Properties of a New Angiotensin Type 1 Receptor Blocker, Azilsartan, in Receptor Binding and Function Studies

(2010) M. Ojima et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Telmisartan inhibits cytokine-induced nuclear factor-κB activation independently of the peroxisome proliferator-activated receptor-γ

(2009) Ayuko Nakano et al.   HYPERTENSION RESEARCH

PERSPECTIVE ARTICLE: Growth factors and cytokines in wound healing

(2008) Stephan Barrientos et al.   WOUND REPAIR AND REGENERATION